IRS2 and Insulin resistance: These data suggest that M2a-subtype MΦ activation via the IL-4/Irs2 pathway is maintained in MIRKO mice, resulting in reduced inflammation and insulin resistance, as Irs2 expression in the MΦs of the MIRKO mice is not downregulated by insulin.